Cargando…

Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line

Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Bery, Nicolas, Favre, Gilles, Olichon, Aurélien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786126/
https://www.ncbi.nlm.nih.gov/pubmed/33437969
http://dx.doi.org/10.1016/j.xpro.2020.100249
_version_ 1783632564933623808
author Bery, Nicolas
Favre, Gilles
Olichon, Aurélien
author_facet Bery, Nicolas
Favre, Gilles
Olichon, Aurélien
author_sort Bery, Nicolas
collection PubMed
description Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell line. The protocol can be used to study the function of RHOB active conformation in various cellular settings. This protocol can be broadly applied to select any kind of intracellular antibody degraders, regardless of conformational state. For complete details on the use and execution of this protocol, please refer to Bery et al. (2019).
format Online
Article
Text
id pubmed-7786126
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77861262021-01-11 Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line Bery, Nicolas Favre, Gilles Olichon, Aurélien STAR Protoc Protocol Here, we provide a protocol for the selection of conformation-specific intracellular antibody degraders using a cell-based screening method. We applied this protocol to select antibody-based degraders targeting the active form of the small GTPase RHOB (i.e., RHOB-GTP) using an engineered H2882 cell line. The protocol can be used to study the function of RHOB active conformation in various cellular settings. This protocol can be broadly applied to select any kind of intracellular antibody degraders, regardless of conformational state. For complete details on the use and execution of this protocol, please refer to Bery et al. (2019). Elsevier 2020-12-30 /pmc/articles/PMC7786126/ /pubmed/33437969 http://dx.doi.org/10.1016/j.xpro.2020.100249 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Bery, Nicolas
Favre, Gilles
Olichon, Aurélien
Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
title Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
title_full Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
title_fullStr Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
title_full_unstemmed Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
title_short Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
title_sort protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786126/
https://www.ncbi.nlm.nih.gov/pubmed/33437969
http://dx.doi.org/10.1016/j.xpro.2020.100249
work_keys_str_mv AT berynicolas protocoltoselectconformationspecificintracellularantibodiesfortargetedproteindegradationinanengineeredcellline
AT favregilles protocoltoselectconformationspecificintracellularantibodiesfortargetedproteindegradationinanengineeredcellline
AT olichonaurelien protocoltoselectconformationspecificintracellularantibodiesfortargetedproteindegradationinanengineeredcellline